B02
Chemical Name: 3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone
Purity: ≥98%
Biological Activity
B02 is a RAD51 recombinase inhibitor, exhibiting selectivity for human RAD51 over the E.coli homologue RecA (IC50 values are 27.4 μM and >250 μM, respectively). Inhibits homologous recombination and increases cellular sensitivity to DNA damage in vitro. Enhances the therapeutic effect of cisplatin (Cat. No. 2251) on tumor cells in vivo.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Identification of specific inhibitors of human RAD51 recombinase using high-throughputscreening.
Huang et al.
ACS Chem.Biol., 2011;6:682 -
Inhibition of homologous recombination in human cells by targeting RAD51 recombinase.
Huang et al.
J.Med.Chem., 2012;55:3011 -
A small molecule inhibitor of human RAD51 potentiates breast cancer cell killing by therapeuticagents in mouse xenografts.
Huang and Mazin
PLoS One, 2014;9:e100993 -
A small-molecule inhibitor of RAD51 reduces homologous recombination and sensitizes multiple myeloma cells to dox.
Alagpulinsa et al.
Front.Oncol., 2014;4:289
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for B02
There are currently no reviews for this product. Be the first to review B02 and earn rewards!
Have you used B02?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
